Talas, Mary Jane L.
HRN: 27-08-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2025
CEFUROXIME 1.5GM (VIAL)
05/09/2025
05/09/2025
IVT
1.5
PTOR
CS
Waiting Final Action
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes